| RS1846929742 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS1846937833 |
LDB3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1C, Dilated cardiomyopathy 1C |
| RS1846942056 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS1846942383 |
LDB3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1C, Dilated cardiomyopathy 1C |
| RS184697035 |
ADNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1846978970 |
CWF19L1
|
Health Risk |
Likely pathogenic |
— |
| RS1846980272 |
SETX
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS184700656 |
MSX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniosynostosis syndrome, Hypoplastic enamel-onycholysis-hypohidrosis syndrome |
| RS1847031671 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS184703595 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS184704952 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1847078623 |
SLC29A3
|
Health Risk |
Conflicting classifications of pathogenicity |
H syndrome, H syndrome |
| RS184708484 |
VANGL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sacral defect with anterior meningocele, Neural tube defect |
| RS1847094674 |
SLC29A3
|
Health Risk |
Conflicting classifications of pathogenicity |
H syndrome, H syndrome |
| RS184709736 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1847100683 |
SETX
|
Health Risk |
Likely pathogenic |
Ataxia, early-onset |
| RS1847126002 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847126581 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847128695 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS184713215 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS184715593 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1847160690 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1847161579 |
BAG3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1847165958 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847169064 |
BAG3
|
Health Risk |
Pathogenic |
— |
| RS1847174277 |
FGFR2
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1847180082 |
TNNI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Distal arthrogryposis type 2B1 |
| RS1847181948 |
TNNI2
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 2B1, Distal arthrogryposis type 2B1 |
| RS1847186675 |
POLR3A
|
Health Risk |
Likely pathogenic |
— |
| RS1847187823 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847193508 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS184719603 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia, Stiff skin syndrome |
| RS1847196520 |
WDR11
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 14 with or without anosmia, Hypogonadotropic hypogonadism 14 with or without anosmia |
| RS1847218494 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847221082 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847222071 |
PNLIP
|
Health Risk |
Likely pathogenic |
— |
| RS184722374 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS184722381 |
SGCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS184723350 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1847236072 |
BAG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847236575 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS184723737 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1847237761 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847238300 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847242923 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS1847246944 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS1847274393 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847288716 |
PNLIP
|
Health Risk |
Pathogenic |
— |
| RS184730597 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS1847315177 |
PNLIP
|
Health Risk |
Pathogenic |
— |
| RS1847324956 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847325791 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS184732617 |
GFM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1847337857 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS1847342207 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS1847352468 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS184735364 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Autosomal dominant nonsyndromic hearing loss 10 |
| RS1847364209 |
POLR3A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS184739336 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, SOS2-related disorder |
| RS1847395828 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
POLR3A-related disorder, POLR3A-related disorder |
| RS1847424990 |
POLR3A
|
Health Risk |
Likely pathogenic |
— |
| RS1847443896 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS184745027 |
FAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS184745422 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS184746130 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Proteinuria |
| RS184748520 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 3, PCLO-related disorder |
| RS1847510893 |
FGFR2
|
Health Risk |
Pathogenic |
Levy-Hollister syndrome, Levy-Hollister syndrome |
| RS1847513733 |
HBB
|
Health Risk |
Pathogenic |
Beta-thalassemia major, Inborn genetic diseases |
| RS1847516043 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847517857 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1847518799 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847520793 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847521496 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1847523960 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847527770 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS1847534399 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1847534434 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847534694 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1847536038 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1847537515 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847537565 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS184754468 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Malignant tumor of urinary bladder |
| RS1847551520 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847552371 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1847552816 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847553344 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847553498 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847553585 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847553982 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847554171 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847554565 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847555115 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847556466 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS1847557333 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847557422 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847557540 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847558511 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS184755865 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1847559573 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1847560327 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |